Literature DB >> 7690895

Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A.

A Pfohl-Leszkowicz1, Y Grosse, A Kane, E E Creppy, G Dirheimer.   

Abstract

Ochratoxin A (OTA) is a mycotoxin which has been implicated in Balkan endemic nephropathy, a disease characterized by a high incidence of urinary tract tumors. It induces DNA single-strand breaks and has been shown to be carcinogenic in two rodent species. For a better understanding of the OTA genotoxic effect, OTA-DNA adduct formation and disappearance has been measured using the 32P-post-labelling method after oral administration of 2.5 mg/kg of OTA to mice. In kidney, liver and spleen, several modified nucleotides were clearly detected in DNA, 24 h after administration of OTA, but their level varied significantly in a tissue and time dependent manner over a 16-day period. Total DNA adducts reached a maximum at 48 h when 103, 42 and 2.2 adducts per 10(9) nucleotides were found respectively in kidney, liver and spleen, indicating that kidney is the main target of the genotoxicity and likely carcinogenicity of OTA. The major adduct differed between kidney and liver. All adducts disappeared in liver and spleen 5 days after compound administration, whereas some adducts persisted for at least 16 days in the kidney. Some adducts were organ specific. The finding that the adducts are not quantitatively and qualitatively the same in the three organs examined is likely due to differences of metabolism in these organs, leading to different ultimate carcinogens and may also result from differences in the efficiency of repair processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690895     DOI: 10.1016/0027-5107(93)90077-s

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  17 in total

1.  Mycotoxins as human carcinogens-the IARC Monographs classification.

Authors:  Vladimir Ostry; Frantisek Malir; Jakub Toman; Yann Grosse
Journal:  Mycotoxin Res       Date:  2016-11-25       Impact factor: 3.833

2.  Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha.

Authors:  W Föllmann; I E Hillebrand; E E Creppy; H M Bolt
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney.

Authors:  S Obrecht-Pflumio; Y Grosse; A Pfohl-Leszkowicz; G Dirheimer
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

4.  Silibinin pretreatment protects against ochratoxin A-mediated apoptosis in primary rat hepatocytes.

Authors:  E Essid; E Petzinger
Journal:  Mycotoxin Res       Date:  2011-04-19       Impact factor: 3.833

5.  Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress.

Authors:  Nieves Palma; Serena Cinelli; Orazio Sapora; Samuel H Wilson; Eugenia Dogliotti
Journal:  Chem Res Toxicol       Date:  2007-06-14       Impact factor: 3.739

6.  Metabolites of ochratoxins in rat urine and in a culture of Aspergillus ochraceus.

Authors:  H Xiao; R R Marquardt; D Abramson; A A Frohlich
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

Review 7.  The involvement of mycotoxins in the development of endemic nephropathy.

Authors:  Maja Peraica; Ana-Marija Domijan; Marica Miletić-Medved; Radovan Fuchs
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 8.  Ochratoxins-food contaminants: impact on human health.

Authors:  Lalini Reddy; Kanti Bhoola
Journal:  Toxins (Basel)       Date:  2010-04-20       Impact factor: 4.546

9.  Studies on carcinogenic and toxic effects of ochratoxin A in chicks.

Authors:  Stoycho D Stoev
Journal:  Toxins (Basel)       Date:  2010-04-12       Impact factor: 4.546

10.  Mutagenicity of ochratoxin A and its hydroquinone metabolite in the SupF gene of the mutation reporter plasmid Ps189.

Authors:  Steven A Akman; Marissa Adams; Doug Case; Gyungse Park; Richard A Manderville
Journal:  Toxins (Basel)       Date:  2012-04-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.